BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7042842)

  • 21. Early diagnosis of relapse in acute myeloblastic leukemia: Serologic detection of leukemia-associated antigens in human marrow.
    Baker MA; Falk JA; Carter WH; Taub RN
    N Engl J Med; 1979 Dec; 301(25):1353-7. PubMed ID: 388224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of series of monoclonal antibodies against human white cell differentiation antigens and the common ALL antigen in the characterization of leukemia cells.
    Hołowiecki J; Stella-Hołowiecka B; Krawczyk-Kuliś M; Wiechnik E; Japa J; Jarczok K; Rudzka E; Duraj M
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):43-9. PubMed ID: 6433853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
    Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
    Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for tumor specific reactivity in human leukemias.
    Nadkarni JS; Nadkarni JJ; Gollerkeri MP
    Indian J Cancer; 1973 Sep; 10(3):338-45. PubMed ID: 4594680
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
    Paietta E; Meenan B; Heavey C; Thomas D
    Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface membrane antigens of hemopoietic tumor cell lines and normal marrow progenitor cells.
    Hasthorpe S; Rogerson J; McKenzie IF
    Cancer Res; 1981 Oct; 41(10):3985-91. PubMed ID: 7285008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antigens associated with human leukemia].
    Doré JF; Bertoglio J; Guibout C
    Bull Cancer; 1976; 63(3):353-70. PubMed ID: 826295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of human myelogenous leukemia cells in the fluorescence-activated cell sorter using a tumor-specific antiserum.
    Malcolm AJ; Logan PM; Shipman RC; Kurth R; Levy JG
    Blood; 1983 May; 61(5):858-66. PubMed ID: 6338975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay in screening of leukemia-associated nuclear proteins.
    Rogalińska M; Błoński J; Robak T; Kiliańska ZM
    Cell Mol Biol Lett; 2001; 6(3):637-48. PubMed ID: 11598639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of human leukemia by membrane antigen analysis with xenoantisera.
    Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
    Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
    Wahren B; Gahrton G; Hammarström S
    Cancer Res; 1980 Jun; 40(6):2039-44. PubMed ID: 6929221
    [No Abstract]   [Full Text] [Related]  

  • 32. A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.
    Fäldt R; Ankerst J
    Cancer Immunol Immunother; 1983; 15(2):69-77. PubMed ID: 6223693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appearance of abnormal catalase antigen and concurrent deletion of normal antigen in leukocytes of myelogenous leukemia.
    Nishimura ET; Hokama Y; Jim R
    Cancer Res; 1972 Nov; 32(11):2353-8. PubMed ID: 4117177
    [No Abstract]   [Full Text] [Related]  

  • 35. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro induction of chronic myeloid leukemia associated immune reactivity in normal human lymphocytes by xenogeneic immune RNA.
    Karande AA; Advani SH; Gangal SG
    Neoplasma; 1983; 30(4):403-9. PubMed ID: 6193434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of human lymphocytes reactive with autologous leukemia cells.
    Csako G; Binder RA; Kales AN; Neefe JR
    Cancer Res; 1980 Sep; 40(9):3218-21. PubMed ID: 6159073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of membrane-associated determinants is an outgrowth of their metabolism.
    Cohen EP
    Prog Clin Biol Res; 1980; 42():145-68. PubMed ID: 6248890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal antigens in human leukemia.
    Granatek CH; Hanna MG; Hersh EM; Gutterman JU; Mavligit GM; Candler EL
    Cancer Res; 1976 Sep; 36(9 PT 2):3464-70. PubMed ID: 975105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.